Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
MedTech
Medline sets terms for massive $5.37B Nasdaq IPO
The medical device manufacturing and distribution giant could claim a valuation of about $55 billion if it reaches the top of its range.
Conor Hale
Dec 9, 2025 11:19am
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
Lumexa Imaging eyes IPO expected to raise $200M
Nov 19, 2025 12:28pm
DNA test maker BillionToOne raises $314M in IPO, shares dip
Nov 10, 2025 8:45am
MapLight goes public via $250M IPO to fund Cobenfy competitor
Oct 27, 2025 6:45am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am